Innovative program connects bariatric surgery and kidney transplant access for patients who have obesity and end-stage renal disease
top of page
Browse by category
Search
A collaborative study between bariatric and transplant teams has created a viable pathway for patients with obesity who also have...
Journal Watch 13/3/2024
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Fractyl’s Rejuva platform demonstrates potent and durable effects of a single dose of a human GLP-1 pancreatic gene therapy transgene vs semaglutide for diabetes and obesity
Fractyl Health has revealed promising new preclinical findings for the first clinical candidate in its Rejuva pancreatic gene therapy...
FDA approves Wegovy for CVD risk reduction in people with overweight or obesity and established cardiovascular disease
The FDA has approved a label expansion for Wegovy based on a supplemental New Drug Application (sNDA) for the indication of reducing...
GLP-1 RA linked to increased residual gastric content before anaesthesia
Safety concerns for patients undergoing anaesthesia who use glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been revealed in a...
SASI bypass and OAGB more effective than SG in the treatment of metabolic syndrome
A retrospective analysis of sleeve gastrectomy (SG), one-anastomotic gastric bypass (OAGB) and single anastomosis sleeve ileal (SASI)...
Browse by tag
bottom of page